Sirona Biochem Corp.
SRBCF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Revenue | $35 | $672 | $268 | $106 |
| % Growth | -94.8% | 150.7% | 153.5% | – |
| Cost of Goods Sold | $64 | $50 | $69 | $54 |
| Gross Profit | -$29 | $622 | $199 | $52 |
| % Margin | -82.7% | 92.5% | 74.3% | 48.8% |
| R&D Expenses | $1,200 | $1,080 | $1,154 | $1,309 |
| G&A Expenses | $930 | $2,673 | $1,075 | $2,601 |
| SG&A Expenses | $930 | $2,673 | $1,075 | $2,601 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $352 | $457 | $317 | $181 |
| Operating Expenses | $2,483 | $4,209 | $2,547 | $4,091 |
| Operating Income | -$2,406 | -$3,568 | -$2,347 | -$4,040 |
| % Margin | -6,917.6% | -531.1% | -875.8% | -3,821.3% |
| Other Income/Exp. Net | -$32 | $16 | $35 | -$101 |
| Pre-Tax Income | -$2,544 | -$3,552 | -$2,312 | -$4,141 |
| Tax Expense | -$1 | $6 | -$6 | -$7 |
| Net Income | -$2,543 | -$3,558 | -$2,306 | -$4,134 |
| % Margin | -7,312.4% | -529.5% | -860.5% | -3,910.4% |
| EPS | -0.01 | -0.015 | -0.01 | -0.018 |
| % Growth | 31.8% | -46.5% | 44.8% | – |
| EPS Diluted | -0.01 | -0.015 | -0.01 | -0.018 |
| Weighted Avg Shares Out | 252,101 | 241,039 | 229,216 | 226,028 |
| Weighted Avg Shares Out Dil | 252,101 | 241,039 | 229,216 | 226,028 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $202 | $27 | $3 | $13 |
| Depreciation & Amortization | $10 | $9 | $9 | $10 |
| EBITDA | -$2,333 | -$3,516 | -$2,299 | -$4,118 |
| % Margin | -6,707.4% | -523.2% | -857.8% | -3,895.5% |